Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Behrendt

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Alimentary Pharmacology & Therapeutics|November 10, 2022
Application of CT contrast medium is not associated with an increased risk for acute kidney injury in patients with decompensated cirrhosisTammo L Tergast, Benjamin Schulte, Marie Griemsmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 1, 2025
Design and Analysis of Novel HEV Vaccine Variants and Evaluation of Two Selected Candidates in a Porcine Infection ModelIsabella Hrabal, Elmira Aliabadi, Saskia Weber, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2019
Chronic Hepatitis E is associated with cholangitisAndrea Beer, Heidemarie Holzmann, Sven Pischke, et al.
Hepatology (Baltimore, Md.)|June 19, 2023
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patientsAndré Gömer, Mara Klöhn, Michelle Jagst, et al.
Cells|March 25, 2022
Viral Interference of Hepatitis C and E Virus Replication in Novel Experimental Co-Infection SystemsThomas Burkard, Nora Proske, Kathrin Resner, et al.
Journal of Hepatology|July 7, 2020
Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E - The HepNet SofE pilot studyMarkus Cornberg, Sven Pischke, Tobias Müller, et al.
Deutsches Arzteblatt International|August 1, 2022
Metamizole-Associated Risks in Decompensated Hepatic CirrhosisBenjamin Schulte, Tammo L Tergast, Marie Griemsmann, et al.
Cells|June 21, 2019
Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human LiverVolker Kinast, Stefan L Leber, Richard J P Brown, et al.
Gut|May 26, 2016
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genomeDaniel Todt, Anett Gisa, Aleksandar Radonic, et al.
Gut|December 16, 2020
Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodiesDorothea Bankwitz, Akash Bahai, Maurice Labuhn, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Alimentary Pharmacology & Therapeutics|November 10, 2022
Application of CT contrast medium is not associated with an increased risk for acute kidney injury in patients with decompensated cirrhosisTammo L Tergast, Benjamin Schulte, Marie Griemsmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 1, 2025
Design and Analysis of Novel HEV Vaccine Variants and Evaluation of Two Selected Candidates in a Porcine Infection ModelIsabella Hrabal, Elmira Aliabadi, Saskia Weber, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2019
Chronic Hepatitis E is associated with cholangitisAndrea Beer, Heidemarie Holzmann, Sven Pischke, et al.
Hepatology (Baltimore, Md.)|June 19, 2023
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patientsAndré Gömer, Mara Klöhn, Michelle Jagst, et al.
Cells|March 25, 2022
Viral Interference of Hepatitis C and E Virus Replication in Novel Experimental Co-Infection SystemsThomas Burkard, Nora Proske, Kathrin Resner, et al.
Journal of Hepatology|July 7, 2020
Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E - The HepNet SofE pilot studyMarkus Cornberg, Sven Pischke, Tobias Müller, et al.
Deutsches Arzteblatt International|August 1, 2022
Metamizole-Associated Risks in Decompensated Hepatic CirrhosisBenjamin Schulte, Tammo L Tergast, Marie Griemsmann, et al.
Cells|June 21, 2019
Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human LiverVolker Kinast, Stefan L Leber, Richard J P Brown, et al.
Gut|May 26, 2016
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genomeDaniel Todt, Anett Gisa, Aleksandar Radonic, et al.
Gut|December 16, 2020
Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodiesDorothea Bankwitz, Akash Bahai, Maurice Labuhn, et al.
Pageof 7